Boston Scientific
Data Driven Decision Making: New EMINENT and RANGER II SFA Evidence in Practice
Facilitated by an expert panel of physician faculty, this interactive discussion centers around deconstructing current data on drug-eluting technology and how to determine which drug-eluting therapy to select based on complexity of lesions.
Login to view comments.
Click here to Login
